Nan Li

Nan Li

Director/Board Member at ODYSSEY THERAPEUTICS, INC.
40 year
Technology Services
Health Technology
Commercial Services

Profile

Nan Li is the founder of Dimension Management LP, founded in 2022, serving as Managing Partner.
Current jobs include Director at Fiveonefour Labs, Inc., Automata Technologies Ltd., Tamarind Bio, Inc., and Aspect Biosystems Ltd. Mr. Li is Independent Director at Odyssey Therapeutics, Inc. starting in 2025.
Mr. Li is Investor & Board Director at Inato SAS since 2019, DarwinAI Corp.
since 2018, and Octave Health Group, Inc. since 2019.
Mr. Li is Board of Director at Hatfield, Inc. since 2017.
Mr. Li is Investor & Board Observer at Recursion Pharmaceuticals, Inc. since 2016, Zymergen, Inc. since 2013, Swiftscale Biologics, Inc. since 2020, and Anagenex, Inc. since 2020.
Mr. Li is Investor at Tempo Automation, Inc. since 2015, Dyno Therapeutics, Inc. since 2018, and n8n GmbH since 2019.
Former jobs include Director at Inato, Inc., Iterative Health, Inc., Gandeeva Therapeutics, Inc., Darwin, Inc., Anagenix Ltd., LabGenius Ltd., and Dexterity, Inc. (California).
Mr. Li was Director & Investor at Dexterity, Inc. (California).
Mr. Li was Managing Director at Obvious Management Services LLC from 2015 to 2022.
Mr. Li was Investor & Board Observer at HookLogic, Inc. from 2010 to 2012, Thorley Industries LLC from 2011 to 2012, Blue River Technology, Inc. from 2013 to 2015, and Formlabs, Inc. from 2013 to 2015.
Mr. Li was Investor at HumanAPI, Inc. from 2014 to 2015 and TPR Education IP Holdings LLC from 2011 to 2012.
Mr. Li was Venture Capital Investor at Bain Capital Ventures LP from 2010 to 2012.
Mr. Li was Principal at Bain & Co., Inc. from 2008 to 2010.
Mr. Li was Investment Partner at Innovation Endeavors LLC from 2013 to 2015.
Mr. Li was Head of Product, Operations & Finance at Sandpiper Labs, Inc. from 2012 to 2013.
Mr. Li was Investor at Planet Labs, Inc. Mr. Li was Investor at Estimote, Inc. from 2013 to 2015.
Education includes undergraduate degree from the University of Michigan.

Nan Li active positions

CompaniesPositionStart
ZYMERGEN INC. Consultant / Advisor 2012-12-31
RECURSION PHARMACEUTICALS, INC. Private Equity Investor 2016-09-30
ODYSSEY THERAPEUTICS, INC. Director/Board Member 2025-05-31
Founder 2022-06-30
Director/Board Member -
Director/Board Member -
Private Equity Investor 2018-10-31
Private Equity Investor 2020-07-31
Private Equity Investor 2019-12-31

Former positions of Nan Li

CompaniesPositionEnd
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Nan Li's experience

Training of Nan Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Consumer Durables

Technology Services

Producer Manufacturing

Technology Services

Health Technology

Finance

Commercial Services

Industrial Services

Consumer Services

Finance

Technology Services

Commercial Services

Commercial Services

Technology Services

Finance

Health Technology

Technology Services

Technology Services

Commercial Services

Health Technology

Health Technology

Technology Services

Technology Services

Technology Services

Technology Services

Health Services

Technology Services

Health Technology

Technology Services

Health Technology

Technology Services

Consumer Services

Commercial Services

Finance